GGrantIndex
← Leaderboards

Kevin Kyung Park

Ut Southwestern Medical Center

$6,854,716
Attributed
$8,207,597
Total exposure
8
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY201325
$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,207,597 · 8

By mechanism

R01$4,490,205 · 3
U01$2,029,321 · 1
R21$1,265,351 · 3
P30$422,720 · 1

Top collaborators

Most similar at Ut Southwestern Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Recovery Of Function

Research focus

Recovery Of FunctionRetinal Ganglion CellsOptic NerveFutureBrainAxonVisionInjuryGenesAxon RegenerationAdultNatural RegenerationOverexpressionOptic Nerve DisorderTraumaGlaucomaAxon InjuryOptic Nerve InjuriesRepairedOptic Nerve RegenerationInjuredMolecularLabelProteins

Grant awards (24)

The role of novel lincRNAs in regulating RGC survival after injury$410,000
R01 · FY2025 · EY · contact PI
Gene Editing and Virus Production Module$211,360
P30 · FY2025 · EY · contact PI
3D visualization and Investigation of Retinal Axon Regeneration$410,000
R01 · FY2024 · EY · contact PI
The role of novel lincRNAs in regulating RGC survival after injury$410,000
R01 · FY2024 · EY · contact PI
Gene Editing and Virus Production Module$211,360
P30 · FY2024 · EY · contact PI
3D visualization and Investigation of Retinal Axon Regeneration$383,750
R01 · FY2023 · EY · contact PI
3D visualization and Investigation of Retinal Axon Regeneration$372,238
R01 · FY2022 · EY · contact PI
Induction and characterization of RGC axon regeneration in models of glaucoma$107,076
R21 · FY2022 · EY · contact PI
Induction and characterization of RGC axon regeneration in models of glaucoma$77,645
R21 · FY2022 · EY · contact PI
3D visualization and Investigation of Retinal Axon Regeneration$383,750
R01 · FY2021 · EY · contact PI
Induction and characterization of RGC axon regeneration in a mouse model of glaucoma$242,137
R21 · FY2021 · EY · contact PI
Assessing Axonal Fate, Myelination and Visual Function Recovery after New Gene Treatment$186,118
R21 · FY2021 · EY · contact PI
Assessing Axonal Fate, Myelination and Visual Function Recovery after New Gene Treatment$230,250
R21 · FY2020 · EY · contact PI
Reconnection of Optic Nerve$383,750
R01 · FY2019 · EY · contact PI
Novel Targets to Promote RGC Axon Regeneration: Insights from Unique RGC Cohorts$667,770
U01 · FY2018 · EY · contact PI
Novel Targets to Promote RGC Axon Regeneration: Insights from Unique RGC Cohorts$675,414
U01 · FY2017 · EY · contact PI
Regeneration and Reconnection of Damaged Optic Nerve$344,250
R01 · FY2017 · EY · contact PI
Development and Characterization of Guided Optic Nerve Regeneration$230,250
R21 · FY2017 · EY · contact PI
Novel Targets to Promote RGC Axon Regeneration: Insights from Unique RGC Cohorts$686,137
U01 · FY2016 · EY · contact PI
Regeneration and Reconnection of Damaged Optic Nerve$344,250
R01 · FY2016 · EY · contact PI
Development and Characterization of Guided Optic Nerve Regeneration$191,875
R21 · FY2016 · EY · contact PI
Regeneration and Reconnection of Damaged Optic Nerve$337,365
R01 · FY2015 · EY · contact PI
Regeneration and Reconnection of Damaged Optic Nerve$347,046
R01 · FY2014 · EY · contact PI
Regeneration and Reconnection of Damaged Optic Nerve$363,806
R01 · FY2013 · EY · contact PI